Media Summary: This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, ... Marjorie G. Zauderer, MD, discusses a currently enrolling Phase 1 CAR-T cell therapy Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center
Mesotv Evolve Meso Clinical Trial - Detailed Analysis & Overview
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, ... Marjorie G. Zauderer, MD, discusses a currently enrolling Phase 1 CAR-T cell therapy Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center Dr. Raffit Hassan of the National Cancer Institute joins us for a conversation about his Jane Churpek, MD, MS, discussed how inherited genetics impact patients with mesothelioma, including the BAP1 gene and the ... Discussion with Dr. Kanwal Raghav regarding a phase II
Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Season 2, Episode 8: In this interview, Dr. Michele Carbone, University of Hawaii, discusses the genetics of mesothelioma, and ... Separately, chemotherapy and immunotherapy are both approved to treat mesothelioma, and individually they work equally well ... Aaron Mansfield, MD, of the Mayo Clinic, discusses a Panel moderated by Kimarie Knowles of Memorial Sloan Kettering Cancer Center. Guests on the panel include mesothelioma ... We meet with Dr. Joseph Friedberg, a thoracic surgeon at Temple University Hospital-Main Campus and Fox Chase Cancer ...
Registered Nurse and Patient Advocate Amy Fair discusses We are joined by Dr. Marjorie Zauderer, a
